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Abstract
This review article summarizes the results of histopathological studies to assess heart failure in
humans. Different histopathological features underlying the clinical manifestations of heart failure
are reviewed. In addition, the present role of echocardiographic techniques in assessing the failing
heart is briefly summarized.
Review
Any cardiac disease may end in congestive heart failure
(CHF), including coronary heart disease. Since mortality
has been reduced in acute coronary syndromes, the latter
will be the main condition resulting in CHF. This concept
stimulated a systematic, quantitative study in 144 hearts
with irreversible insufficiency excised at transplantation
compared with 144 hearts without CHF both from
patients and normal subjects dead from accident [1]. The
aim of this review is to discuss a consensus on CHF which,
independently of the underlying disease, is considered:
"secondary to absolute or relative ischemia, remodelling
of heart shape by enlarged volume, increased mass, car-
diac wall thinning, lengthening of cardiomyocytes, con-
tinuous infarct expansion, scar formation, apoptosis,
hypertrophy, slippage of myocardial cells and increased
interstitial fibrosis, and neurohormonal activation" [2].
Our 144 patients with irreversible CHF included 63 with
chronic coronary heart disease, 63 with dilated cardiomy-
opathy and 18 with chronic valvular heart disease. All had
a similar clinical pattern. The advantage is that surgically
excised hearts are free of any change which may occur in
the terminal, agonic phase and interfere with other autop-
tic findings.
The main data supporting this review are synthesize in
Table 1 and main items in the consensus to be discussed
are:
1. Myocardial fibrosis
This variable assumes a central pathogenic meaning since
it results (ischemia → continuous infarct expansion →
scar) in fibrous, non contracting myocardium ending in
progressive insufficiency. In all the three conditions exam-
ined, the extent of myocardial fibrosis (Figure 1) was una-
ble to explain myocardial global insufficiency. Even in
coronary heart disease group the "fibrous index" (extent
percent of myocardial fibrosis found in 16 histologic
slides in each heart) showed that the amount of histolog-
ically viable myocardium was 83% (98% in dilated cardi-
omyopathy, 94% in chronic valvulopathy). Furthermore,
the increased interstitial fibrosis has ondulate or wavy col-
lagen fibers (Figure 1). This means that collagen fiber
hyperplasia is a secondary adaptation to myocardial
hypertrophy without any blocking effect on contraction. A
last warning is that myocardial fibrosis, especially in large
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scar following an infarct necrosis, often is substituted by
adipose tissue which can be misinterpreted by clinical
imaging concerning myocardial viability [3].
2. Lymphocytic infiltration
In dilated cardiomyopathy the etiopathogenetic hypothe-
sis is that a chronic virus myocarditis resulting in myocar-
dial fibrosis explains this pathologic condition. Both
myocardial fibrosis, as already mentioned, and lym-
phocytic infiltrates, as expression of a virus infection,
showed a too low frequency and extent. In particular the
number of lymphocytic foci was less than controls in all
the insufficient hearts, with a number of elements per
focus less than 20. Only in "silent" Chagas patients
[apparently healthy subjects serum-positive for this dis-
ease who died suddenly and unexpectedly] an extensive
lymphocytic myocarditis associated with catecholamine
necrosis was observed.
3. Ischemia
A clinical study has shown that ischemic episodes are not
part of CHF [4]. On the other hand, in coronary artery dis-
ease + CHF group an acute, silent infarct was detected in
five of 63 hearts, transmural in two and subendocardial in
three with a histological age between 20–30 days. In con-
trols, one Chagas patient had a ten day old anterior infarct
and four AIDS subjects, all with normal coronary arteries
had a microfocal, four day old infarct in the anterior pap-
illary muscle. If ischemia is the cause of CHF we should
have a higher frequency of infarct necrosis.
4. Apoptosis
This genomically programmed cell death, supposed to be
triggered by many risk factors, has been recently advo-
cated to explain different cardiac pathologies in which
apoptosis has been indirectly "demonstrated" by TUNEL
techniques [5]. This necrosis is defined as shrinkage of sin-
gle cell with fragmentation of its nucleus forming "apop-
totic bodies" easy to recognize within or outside the dead
cell. The apoptotic cell then disappears without evidence
of collagen substitution [6], a finding never observed in
our human and experimental material [5]. The claim, that
lost of myocardial cells by apoptosis may explain cardiac
insufficiency, is contradicted by the heavy weight of insuf-
ficient hearts. Lost of myocytes should correspond to nor-
mal, if not subnormal heart weight.
5. Thinning cardiac wall/lengthening of myocytes
The weight/size paradox i.e. heavy heart weight with both
cardiac wall and myocyte normal thickness is explained
by dilatation of heart chambers with lengthening by dis-
tension of myocardial cells resulting in normal wall thick-
ness. Such a stretch of myocytes does not occur [1] as
shown histologically and ultrastructurally (note in Figure
2). Furthermore, congestive heart failure may occur with-
out or with mild chamber enlargement, ventricular dilata-
tion being not an independent prognostic predictor [7].
6. Hypertrophy
By cardiac hypertrophy we mean a tridimensional aug-
mentation in number of myofibrils and other compo-
nents of myocardial cells to compensate an increase of
heart work. The myocyte hypertrophy results in a heavy
cardiac weight. When insufficiency begins the weight/size
paradox can not be explained by longitudinal division of
myocytes never demonstrated or by neogenesis of myo-
cytes [8-10], a concept difficult to be accepted since the
hypertrophying stimulus persists and the new elements
should hypertrophy.
7. Slippage of myocytes
To explain the paradox, the other well granted hypothesis
is that an interpenetration of myocytes may reduce the
cardiac wall thickness. First, such never proved interpene-
tration may explain the latter and dilatation of heart cavi-
ties (Figure 2). However, it does not explain normal
thickness of myocytes and implies that there is a destruc-
tion of a) connecting myobridges between adjacent myo-
cytes b) their interconnection by collagen matrix, and c) a
disruption of all interstitial components as vessels (arte-
rial, terminal bed-capillaries, venous and lymphatics) and
nerves never seen in this condition.
8. Neurohormonal activation
This assumption has a confirmation in the high frequency
of catecholamine necrosis [7] even if the extent of the
lesion is very small (Table 1).
The first conclusion is that the pooling of all items of the
quoted consensus has no support from morphopathol-
ogy, but neurohormonal activation which, per se, does
not explain congestive failure rather an adrenergic stress
prevented by beta-blocking therapy. However, the follow-
ing two findings not mentioned in this consensus are the
following.
9. Colliquative myocytolysis
This non ischemic lesion [7] is typical of congestive heart
failure (Figure 3) and, when other conditions (storage dis-
eases) can be excluded, is a reliable histologic hallmark
consequent to myocyte insufficiency with increasing lost
of myofibrils, intracellular edema in absence of any type
of reaction. Its secondary nature is proved by a lack of rela-
tionship with clinical indexes of CHF.
10. Endomioelastofibrosis
This change is worthy of mention to avoid any confusion
with embologenic endocardial thrombosis. The presence
of the latter was 21% in coronary heart disease, 10% in
dilated cardiomyopathy and 6% of valvulopathic patientsC
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Table 1: Main findings in 144 hearts with and 144 hearts without congestive heart failure
Source Total Age Heart Myocardial fibrosis Intermyocyte lymphocytic infiltration Catecholamine necrosis Colliquative myocytolysis
cases yrs weight trans.Ø Ant.LV no 20% FI absent -Mn +Mn Foci + Foci Myocells no [% cells]
g mm mm < > ×100 mm2 <25 25–50 >50
Ischemic heart 63 51 ± 8 565 ± 108 137 ± 14 12 ± 4 - 11 52 17 ± 8 9 38 17 0.2 ± 0.05 59 1 ± 1 10 ± 14 1 14 39 9
Dilated cardiom. 63 42 ± 12 639 ± 155 148 ± 15 15 ± 4 8 54 1 2 ± 3 8 42 18 0.4 ± 0.18 53 2 ± 6 12 ± 26 3 28 28 4
Valvulopathy 18 46 ± 8 827 ± 179 147 ± 15 16 ± 4 - 14 4 4 ± 4 3 12 7 0.3 ± 0.09 14 1 ± 2 5 ± 6 1 2 14 1
Total+CHF* 144 46 ± 9 677 ± 147 144 ± 15 14 ± 4 8 79 57 8 ± 5 20 92 42 0.3 ± 0.09 126 1 ± 3 9 ± 15 5 44 81 14
Chagas 34 49 ± 13 464 ± 110 114 ± 18 15 ± 3 9 18 7 7 ± 8 - 34 31 13 ± 2 34 3 ± 6 30 ± 51 28 6 - -
AIDS 38 31 ± 10 368 ± 67 91 ± 21 13 ± 3 34 4 - 0.04 ± 1 14 16 9 1.5 ± 0.7 25 4 ± 11 13 ± 27 33 3 2 -
Brain hemorrhage 27 58 ± 12 434 ± 91 107 ± 15 18 ± 7 12 15 - 0.4 ± 6 15 7 - 2 ± 1.8 24 26 ± 34 67 ± 104 26 - 1 -
Head trauma normal 45 42 ± 17 364 ± 47 104 ± 15 12 ± 6 45 - - - 29 11 - 5 ± 3 9*** 10 ± 18 23 ± 31 45 - - -
Total without CHF 144 45 ± 17 408 ± 79 104 ± 17 15 ± 5 100 37 7 2 ± 5 58 68 40 5 ± 1.9 92 11 ± 17 33 ± 53 132 9 3 -
* Heart excised at transplantation; ** Mn, myocyte necrosis non [-] or [+] associated with lymphocytes; *** Survival < 1 hour. No necrosis in instantaneous death; Ant LV, thickness anterior left ventricle; 
trans. Ø, transvers diameterCardiovascular Ultrasound 2007, 5:5 http://www.cardiovascularultrasound.com/content/5/1/5
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with CHF. Most of these endocardial thrombi were organ-
ized. Myoelastofibrosis was demonstrated in 98% of con-
gestive hearts being present also in controls (Table 2). It
starts as smooth muscle cell nodular proliferation below
the normal endothelial cells of the endocardium (Figure
4), followed by elastic fiber hyperplasia and ending in
fibrous thickening without evidence of overimposed
thrombosis or repair process.
Target of Ultrasound Diagnosis: Present and 
Future
Though various imaging techniques have been introduced
for assessing left ventricular function, echocardiography
still represents the main choice in the clinical arena due to
its unique combination of safety, feasibility, and reliabil-
ity (Table 3). Both diastolic and systolic function of the
heart can be easily explored by echocardiography.
Stretched, i.e. elongation of sarcomeres and nuclei in viable myocardial cells in an old aneurysm of the left ventricular wall with  dense fibrosis [A] Figure 1
Stretched, i.e. elongation of sarcomeres and nuclei in viable myocardial cells in an old aneurysm of the left ventricular wall with 
dense fibrosis [A]. Dense and compact fibrosis as end result of a repair process of an infarct. The collagen fibers are straight 
and closed together [B]. In contrast in hearts with congestive heart failure the myocardial fibrosis is very mild [C, D] showing a 
corkscrew aspect of the collagen fibers [E]. This means an adaptation of the collagenogenesis to the contraction cycle without 
any capability to reduce or stop the latter. Furthermore, the fibrous tissue may metaplasize in adipose tissue which substitutes 
large fibrous area [F, G]. A fact to have in mind when quantifying the size of a scar or measuring by nuclear method the myo-
cardial viability.Cardiovascular Ultrasound 2007, 5:5 http://www.cardiovascularultrasound.com/content/5/1/5
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1. Diastolic function
Doppler echocardiography traditionally allows diastolic
abnormalities affecting overall cardiac function to be eas-
ily detected on routine examination. Inversion of the E/A
ratio and prolongation of deceleration time on the trans-
mitral flow pattern represent the first abnormalities which
are encountered in the minor stage of diastolic dysfunc-
tion. A restrictive filling pattern, reflecting an increased
pulmonary capillary pressure, is observed in case of more
severe dysfunction and is associated to adverse outcome
[11]. More recently, Tissue Doppler Imaging (TDI) has
provided robust, relatively unambiguous, well validated
tool that is more reliable than the use of pulmonary vein
Doppler, flow propagation velocity or load altering tech-
niques [12].
The clinical role of echocardiography for evaluating
diastolic function is quite different depending on whether
global left ventricular (LV) systolic function is preserved
or not. In patients with preserved systolic function, meas-
urement of transmitral flow in combination with mitral
annular tissue Doppler velocities provide the most effi-
cient means of assessing LV diastolic function and filling
pressures. However, in case of global systolic dysfunction
and accompanying diastolic dysfunction, the principal
aim of Doppler echocardiography is to estimate filling
pressure, which has known therapeutic and prognostic
Weight/size paradox in congestive heart failure Figure 2
Weight/size paradox in congestive heart failure. The slippage of myocardial cell to explain a normal wall and myocellular size 
despite a heavy cardiac weight [A], does not consider the myofibrillar bridging between myocells and fibrillar collagen connec-
tions. Slippage of myocells, capable to reduce for instance a 3 cm cardiac wall in 1.5 one, should imply an extensive destruction 
of all interstitial structures [vessels, including lymphatics, and nerves] and consequent widespread tissue damage never seen in 
this condition. Even a neogenesis of the myocardial cell was never observed. Only once in an endomyocardial biopsy at a pre-
vious site of sampling in a transplanted heart, we had the opportunity to see new myocells forming a focus of small elements 
assuming the aspect of atrio-ventricular node [B, C]. Just to emphasize that a neogenesis when exists can be seen, apparently 
without integration in the functioning myocardium.Cardiovascular Ultrasound 2007, 5:5 http://www.cardiovascularultrasound.com/content/5/1/5
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implications [13]. In these patients, diastolic Doppler
parameters are principally used to determine LV filling
pressures [13]. Finally, when the regional assessment of
the diastolic function is the target, TDI presently repre-
sents the best echocardiographic approach.
2. Systolic function
Initially described in studies including contrast or radio-
nuclide ventriculography, global and regional left ven-
tricular function are optimally assessed with
echocardiographic technique in both resting and stress
condition. With the ultrasound beam directed perpendic-
ularly to the myocardium, wall motion and thickening
can easily be detected on the imaging plane. Several imag-
ing windows, including parasternal, apical, and subcostal
views, are used to visualize all ventricular walls. More
recently, three dimensional (3D) echocardiographic
images are generated by integration of information from
multiple 2D imaging planes. In addition, the introduction
of harmonic imaging and the use of echocardiographic
contrast media for improved endocardial border defini-
tion have significantly improved image quality, thereby
enhancing the accuracy of assessment of left ventricular
function particularly in patients with poor acoustic win-
Colliquative myocytolysis Figure 3
Colliquative myocytolysis. Progressive disappearance of myofibrils [A], with intramyocardial edema [B] resulting in empty sar-
colemmal tube seen in longitudinal [C] and transverse section [D]. Note the absence of any type of reaction. E, ultrastructural 
view of an edematous myocell filled by mitochondria and few contracted myofibrils in contrast with a normal contracted myo-
cell [F] of the same case with congestive heart failure.Cardiovascular Ultrasound 2007, 5:5 http://www.cardiovascularultrasound.com/content/5/1/5
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dows. Estimation of the LVEF by 2D echocardiography
can be done either qualitatively by visual inspection of
global and regional function or quantitatively, using geo-
metric assumptions regarding the shape of the LV cavity.
Global and regional LV systolic function can both be qual-
itatively and quantitatively assessed with echocardiogra-
phy.
Global function is qualitatively described as normal,
depressed, or hyperdynamic. Although a comprehensive
quantitative assessment of LV end-systolic and end-
diastolic data would be ideal, such an approach is cur-
rently impractical for routine evaluation. Several quantita-
tive approaches have been described, with Simpson's rule
(disk-area method) being the most accurate for LV vol-
ume measurement and for computation of derived values
such as LV ejection fraction [14]. Perhaps this assessment
may be obtained in the future with further development
of 3D techniques and improved automated edge-detec-
tion algorithms.
The regional assessment of LV systolic function is assessed
by dividing the entire left ventricle into segments. The
most popular models recommend the use of 16 or 17 seg-
ments [15,16]. A score is then assigned to each segment:
(1 = normal, 2 = hypokinesis, 3 = akinesis, 4 = dyskinesis)
and a semiquantitative wall motion score index is derived
as the ratio between the sum of scores assigned to each
segment and the number of visualized segments.
Future developments for the assessment of ventricular
function with echocardiography include the use of 3D
technique and myocardial strain imaging.
3D echocardiography offers the theoretical advantage to
provide incremental benefit over 2D techniques in terms
of accuracy and reproducibility and appears to produce
estimation of LV ejection fraction similar to radionuclide
ventriculography and cardiovascular magnetic resonance
[17-21].
The term "strain" refers to an object's fractional or per-
centage change from its original dimension [22,23], thus
reflecting the deformation of a structure. When applied to
the myocardium, strain directly describes the contraction/
relaxation pattern and can be calculated in several dimen-
sions [23]. Strain rate represents the rate of this deforma-
tion [22]. Strain rate imaging involves mathematical
subtraction of the whole heart or translational motion
from regional thickening velocity using a transmural data
set from color-coded tissue Doppler echo [24,25]. This
quantification of the spatial distribution of intramural
velocities across the myocardium has improved the ability
of tissue Doppler echo to reflect directional and incre-
mental alterations in regional and global left ventricular
contractility in patients with cardiovascular disease [24-
27]. Though very promising for assessing several aspect of
myocardial function, strain and strain rate imaging pres-
ently are of limited applicability in clinical practice due to
several limitations [23], such as complex methodology,
technical challenges of image acquisition, susceptibility to
artefact and lack of standardization.
Conclusion
The cause of CHF is still unknown, with the impression,
based on morphopathologic data, that its pathogenesis
consists in a primary metabolic error of myocytes which
lost their ability to relax in the contraction cycle. At
ultrastructure these elements are in contraction and this
finding may indicate the inability to remove Ca+2 from
troponin-tropomyosine complex. The metabolic error
could stimulate an abortive hypertrophy with elongation
of myocytes by new sarcomeres with normal length with-
out tridimensional myofibrillar iperplasia [1,4].
Table 2: Frequency of endocardial myoelastofibrosis in different conditions
Source Endocardial myofibroelastosis
Cases Absent Nodular myohyperplasia Myofibro elastosis LV RV IV
Congestive heart failure* 144 3 15 126 129 29 125
Sudden/unexpected coronary death 25 13 2 10 6 6 9
Sudden/unexpected death silent Chagas 34 15 1 18 17 6 10
Transplanted hearts 46 29 6 11 11 5 6
Intracranial brain hemorrhage 27 10 3 14 13 4 9
AIDS 38 16 7 15 11 5 11
Cocaine abusers** 26 19 5 2 2 - -
Carbon monoxide intoxication** 26 26 - - - - -
Head trauma** 45 45 - - - - -
Electrocution** 21 21 - - - - -
* Hearts excised at transplantation ** Only anterior left ventricle available for study; LV, left ventricle; RV right ventricle; IV, interventricular septumCardiovascular Ultrasound 2007, 5:5 http://www.cardiovascularultrasound.com/content/5/1/5
Page 8 of 9
(page number not for citation purposes)
Endomyoelastofibrosis of the endocardium Figure 4
Endomyoelastofibrosis of the endocardium. Thickening of the endocardium is considered consequent to intracavitary thrombi 
organization. The latter is a relatively rare event. The majority of endocardial thickening is due to the formation of smooth 
muscle cell bundles [A] with hyperelastosis [B] ending in fibrous replacement [C]. A process similar to that shown in the early 
pathogenesis of an atherosclerotic plaque, to keep in mind in relation to antithrombotic therapy.
Table 3: Noninvasive technique for assessing left ventricular function.
Echocardiography Nuclear scan Cardiac CT Cardiac MRI
Radiation exposure - + + -
Patient dependence + - - -
Operator dependence + - - -
Imaging time + ++ + +++
Installation costs + ++ +++ ++++
Operation costs + ++ +++ ++++
Spatial resolution +++ + +++ +++
Temporal resolution +++ + ++ ±
CT: computed tomography
MRI: magnetic resonance imaging
Reproduced from Picano E.: Stress Echocardiography. 4th edition. Verlag: Springer; 2003Publish with BioMed Central    and   every 
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